Reaction
Catheter Site Pruritus reporting signals
As of the last recalculation, Catheter Site Pruritus appears in 864 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 1,475.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 416 | 1,475.5 | 1,524.2 |
| Macitentan | 276 | 140.6 | 141.2 |
| Sildenafil | 197 | 105.8 | 106.2 |
| Treprostinil | 298 | 86.8 | 87.0 |
| Tadalafil | 245 | 81.9 | 82.1 |
| Sildenafil Citrate | 283 | 79.2 | 79.3 |
| Riociguat | 89 | 73.2 | 73.4 |
| Sildenafil Powder, | 87 | 65.4 | 65.5 |
| 0Xygen | 98 | 53.9 | 54.0 |
| Oxygen | 98 | 53.9 | 54.0 |
| Ambrisentan | 207 | 52.2 | 52.3 |
| Selexipag | 34 | 33.0 | 33.0 |
| Bosentan | 63 | 32.4 | 32.4 |
| Bumetanide | 23 | 21.5 | 21.5 |
| Metolazone | 9 | 19.5 | 19.5 |
| Warfarin | 84 | 17.5 | 17.5 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 5 | 3.9 | 3.9 |